(Reuters) — Abbott Laboratories said on Monday that U.S. regulators have withheld approval of its experimental long-acting form of the painkiller Vicodin, leaving it unclear if and when the powerful narcotic might be approved. But Abbott stuck to its earlier company earnings forecasts for ...
